首页> 外文期刊>Powder Technology: An International Journal on the Science and Technology of Wet and Dry Particulate Systems >Soluplus~R: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation
【24h】

Soluplus~R: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation

机译:Soluplus〜R:一种优化卡维地洛固体分散体的新型聚合物增溶剂:配方设计和制备方法的效果

获取原文
获取原文并翻译 | 示例
       

摘要

The aim of this work was to investigate the applicability of different industrially scalable techniques in the preparation of solid dispersions using a novel polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer (Soluplus~R) for preparing immediate-release formulations of a poorly water-soluble BCS class II drug. Carvedilol (CAR), a non-selective β-blocker, has been selected as poorly water-soluble model drug. The solid dispersions were prepared by three different techniques; solvent evaporation, freeze drying and spray drying in different CAR:Soluplus~R ratios using 3~2 full factorial design. Among the formulations tested, CAR solid dispersion preparation using freeze drying method at ratio of 1:10 (CAR: Soluplus~R) showed the highest saturation solubility and was selected for further investigation. Solid state characterization was evaluated by differential scanning calorimetry (DSC) and X-ray diffraction study (XRD), scanning electron microscopy (SEM) and Fourier transformation infrared spectroscopy (FTIR). DSC and XRD analyses indicated the complete transformation of CAR in the solid dispersion from crystalline to amorphous state. Selected CAR solid dispersion was further incorporated into ODTs using three commercially mannitol-based fillers; Pearlitol Flash~R, Pharmaburst~R and Ludifalsh~R. The ODTs were evaluated for hardness, disintegration time and drug dissolution. Pearlitol Flash~R, and Pharmaburst~R ODTs showed shorter disintegration times (<1 min) and significantly higher dissolution profile (>90% within 30 min) compared to Ludifalsh~R ODTs. Thus, the development of CAR solid dispersions using Soluplus~R as ODTs could be used as a promising approach for improving the solubility and oral bioavailability of poorly water-soluble drugs.
机译:这项工作的目的是研究不同的工业可扩展技术在使用新型聚乙烯己内酰胺-聚乙酸乙烯酯-聚乙二醇接枝共聚物(Soluplus®R)制备水难溶性速释制剂的固体分散体中的适用性。可溶性BCS II类药物。卡维地洛(CAR),一种非选择性β受体阻滞剂,已被选为水溶性差的模型药物。固体分散体通过三种不同的技术制备。采用3〜2全因子设计,以不同的CAR:Soluplus〜R比率进行溶剂蒸发,冷冻干燥和喷雾干燥。在测试的配方中,采用冷冻干燥法以1:10的比例(CAR:Soluplus〜R)制备的CAR固体分散体显示出最高的饱和溶解度,因此被选择进行进一步研究。固态表征通过差示扫描量热法(DSC)和X射线衍射研究(XRD),扫描电子显微镜(SEM)和傅里叶变换红外光谱(FTIR)进行评估。 DSC和XRD分析表明固体分散体中CAR从晶态到非晶态的完全转变。使用三种市售甘露醇基填料将选定的CAR固体分散体进一步掺入ODT中。 Pearlitol Flash〜R,Pharmaburst〜R和Ludifalsh〜R。对ODT进行了硬度,崩解时间和药物溶解的评估。与Ludifalsh〜R ODT相比,Pearlitol Flash〜R和Pharmaburst〜R ODT显示出更短的崩解时间(<1分钟)和显着更高的溶出曲线(在30分钟内> 90%)。因此,使用Soluplus〜R作为ODTs的CAR固体分散体的开发可以用作改善水溶性差的药物的溶解度和口服生物利用度的有前途的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号